228 related articles for article (PubMed ID: 29540187)
1. MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia.
Ma QL; Wang JH; Yang M; Wang HP; Jin J
J Transl Med; 2018 Mar; 16(1):68. PubMed ID: 29540187
[TBL] [Abstract][Full Text] [Related]
2. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.
Jinlong S; Lin F; Yonghui L; Li Y; Weidong W
PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775
[TBL] [Abstract][Full Text] [Related]
3. High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts.
Wang J; Li F; Ma Z; Yu M; Guo Q; Huang J; Yu W; Wang Y; Jin J
EBioMedicine; 2018 Feb; 28():90-96. PubMed ID: 29402726
[TBL] [Abstract][Full Text] [Related]
4. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
Huang Y; Zou Y; Lin L; Ma X; Chen H
Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
[TBL] [Abstract][Full Text] [Related]
5. Plasma exosome-derived microRNA-532 as a novel predictor for acute myeloid leukemia.
Lin X; Ling Q; Lv Y; Ye W; Huang J; Li X; Guo Q; Wang J; Li Z; Jin J
Cancer Biomark; 2020; 28(2):151-158. PubMed ID: 32176633
[TBL] [Abstract][Full Text] [Related]
6. The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.
Díaz-Beyá M; Brunet S; Nomdedéu J; Cordeiro A; Tormo M; Escoda L; Ribera JM; Arnan M; Heras I; Gallardo D; Bargay J; Queipo de Llano MP; Salamero O; Martí JM; Sampol A; Pedro C; Hoyos M; Pratcorona M; Castellano JJ; Nomdedeu M; Risueño RM; Sierra J; Monzó M; Navarro A; Esteve J
Blood Cancer J; 2015 Oct; 5(10):e352. PubMed ID: 26430723
[TBL] [Abstract][Full Text] [Related]
7. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.
Zhang TJ; Wu DH; Zhou JD; Li XX; Zhang W; Guo H; Ma JC; Deng ZQ; Lin J; Qian J
J Cell Physiol; 2018 Apr; 233(4):3274-3281. PubMed ID: 28884855
[TBL] [Abstract][Full Text] [Related]
9. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.
Bhayadia R; Krowiorz K; Haetscher N; Jammal R; Emmrich S; Obulkasim A; Fiedler J; Schwarzer A; Rouhi A; Heuser M; Wingert S; Bothur S; Döhner K; Mätzig T; Ng M; Reinhardt D; Döhner H; Zwaan CM; van den Heuvel Eibrink M; Heckl D; Fornerod M; Thum T; Humphries RK; Rieger MA; Kuchenbauer F; Klusmann JH
J Clin Oncol; 2018 Apr; 36(10):1007-1016. PubMed ID: 29432078
[TBL] [Abstract][Full Text] [Related]
10. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
Shi JL; Fu L; Wang WD
Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
[TBL] [Abstract][Full Text] [Related]
11. MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy.
Yang C; Shao T; Zhang H; Zhang N; Shi X; Liu X; Yao Y; Xu L; Zhu S; Cao J; Cheng H; Yan Z; Li Z; Niu M; Xu K
J Transl Med; 2018 Oct; 16(1):267. PubMed ID: 30285885
[TBL] [Abstract][Full Text] [Related]
12. miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia.
Eisfeld AK; Marcucci G; Maharry K; Schwind S; Radmacher MD; Nicolet D; Becker H; Mrózek K; Whitman SP; Metzeler KH; Mendler JH; Wu YZ; Liyanarachchi S; Patel R; Baer MR; Powell BL; Carter TH; Moore JO; Kolitz JE; Wetzler M; Caligiuri MA; Larson RA; Tanner SM; de la Chapelle A; Bloomfield CD
Blood; 2012 Jul; 120(2):249-58. PubMed ID: 22529287
[TBL] [Abstract][Full Text] [Related]
13. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia.
Niederwieser C; Kohlschmidt J; Volinia S; Whitman SP; Metzeler KH; Eisfeld AK; Maharry K; Yan P; Frankhouser D; Becker H; Schwind S; Carroll AJ; Nicolet D; Mendler JH; Curfman JP; Wu YZ; Baer MR; Powell BL; Kolitz JE; Moore JO; Carter TH; Bundschuh R; Larson RA; Stone RM; Mrózek K; Marcucci G; Bloomfield CD
Leukemia; 2015 Mar; 29(3):567-75. PubMed ID: 25204569
[TBL] [Abstract][Full Text] [Related]
15. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
[TBL] [Abstract][Full Text] [Related]
16. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia.
Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J
Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222
[TBL] [Abstract][Full Text] [Related]
17. A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.
Zhu R; Zhao W; Fan F; Tang L; Liu J; Luo T; Deng J; Hu Y
Oncotarget; 2017 Jun; 8(24):38902-38913. PubMed ID: 28473658
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.
Zhou JD; Zhang LC; Zhang TJ; Gu Y; Wu DH; Zhang W; Ma JC; Wen XM; Guo H; Lin J; Qian J
J Transl Med; 2018 May; 16(1):135. PubMed ID: 29784043
[TBL] [Abstract][Full Text] [Related]
19. MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation.
Seipel K; Messerli C; Wiedemann G; Bacher U; Pabst T
Leuk Res; 2020 Feb; 89():106296. PubMed ID: 31927137
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of miR-196a/b expression in adult acute myeloid leukaemia: a single-centre, retrospective cohort study.
Zhang J; Liu W; Du J; Jin Y; Zhao M; Li L; Wang Y
J Int Med Res; 2018 Sep; 46(9):3675-3683. PubMed ID: 29865918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
